Logo image of IZTC

INVIZYNE TECHNOLOGIES INC (IZTC) Stock Price, Quote, News and Overview

NASDAQ:IZTC - Nasdaq - US4618741098 - Common Stock - Currency: USD

16.5  +1 (+6.45%)

IZTC Quote, Performance and Key Statistics

INVIZYNE TECHNOLOGIES INC

NASDAQ:IZTC (2/11/2025, 8:00:02 PM)

16.5

+1 (+6.45%)

Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology
Statistics
52 Week HighN/A
52 Week LowN/A
Market Cap134.15M
Shares8.13M
Float1.92M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO11-13 2024-11-13


IZTC short term performance overview.The bars show the price performance of IZTC in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 20 30 40

IZTC long term performance overview.The bars show the price performance of IZTC in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of IZTC is 16.5 USD. In the past month the price increased by 50%.

INVIZYNE TECHNOLOGIES INC / IZTC Daily stock chart

IZTC Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 18.04 327.31B
AMGN AMGEN INC 13.94 155.58B
GILD GILEAD SCIENCES INC 14.02 134.97B
VRTX VERTEX PHARMACEUTICALS INC N/A 113.22B
REGN REGENERON PHARMACEUTICALS 11.5 55.03B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 40.38B
ARGX ARGENX SE - ADR 94.29 33.10B
ONC BEONE MEDICINES LTD-ADR 6.33 26.73B
BNTX BIONTECH SE-ADR N/A 25.61B
NTRA NATERA INC N/A 23.47B
INSM INSMED INC N/A 18.70B
BIIB BIOGEN INC 8.03 18.62B

About IZTC

Company Profile

Invizyne Technologies Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Monrovia California, California and currently employs 29 full-time employees. The company went IPO on 2024-11-13. Invizyne Technologies, Inc. is a biotechnology, pre-revenue, development stage company. The firm's cell-free technology expands its ability to perform enzyme-based conversions, guiding towards sustainable biomanufacturing. The firm is primarily engaged in the development of the SimplePath platform. Its SimplePath platform consists of a series of enzyme based biomanufacturing systems that leverage natural processes to perform complex chemical conversions that convert a starting material into a desired end-product. Each SimplePath system is composed of one or more modules which consist of one or more enzymes that work together to perform a defined biocatalytic conversion. The company can provide solutions for natural ingredients (cannabinoids, flavor enhancers for food and beverage products, fragrances, nutraceuticals, organic compounds), pharmaceuticals (natural products with therapeutic properties) and chemicals (commodity chemicals, specialty chemicals, biofuels).

Company Info

INVIZYNE TECHNOLOGIES INC

750 Royal Oaks Drive, Suite 106

Monrovia California CALIFORNIA US

Employees: 29

IZTC Company Website

Phone: 16264151488

INVIZYNE TECHNOLOGIES INC / IZTC FAQ

What is the stock price of INVIZYNE TECHNOLOGIES INC today?

The current stock price of IZTC is 16.5 USD. The price increased by 6.45% in the last trading session.


What is the ticker symbol for INVIZYNE TECHNOLOGIES INC stock?

The exchange symbol of INVIZYNE TECHNOLOGIES INC is IZTC and it is listed on the Nasdaq exchange.


On which exchange is IZTC stock listed?

IZTC stock is listed on the Nasdaq exchange.


What is INVIZYNE TECHNOLOGIES INC worth?

INVIZYNE TECHNOLOGIES INC (IZTC) has a market capitalization of 134.15M USD. This makes IZTC a Micro Cap stock.


How many employees does INVIZYNE TECHNOLOGIES INC have?

INVIZYNE TECHNOLOGIES INC (IZTC) currently has 29 employees.


What are the support and resistance levels for INVIZYNE TECHNOLOGIES INC (IZTC) stock?

INVIZYNE TECHNOLOGIES INC (IZTC) has a support level at 15.5 and a resistance level at 16.76. Check the full technical report for a detailed analysis of IZTC support and resistance levels.


Should I buy INVIZYNE TECHNOLOGIES INC (IZTC) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does INVIZYNE TECHNOLOGIES INC (IZTC) stock pay dividends?

IZTC does not pay a dividend.


What is the Price/Earnings (PE) ratio of INVIZYNE TECHNOLOGIES INC (IZTC)?

INVIZYNE TECHNOLOGIES INC (IZTC) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.25).


IZTC Technical Analysis

ChartMill assigns a technical rating of 5 / 10 to IZTC.


Chartmill TA Rating
Chartmill Setup Rating

IZTC Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to IZTC. Both the profitability and financial health of IZTC have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

IZTC Financial Highlights

Over the last trailing twelve months IZTC reported a non-GAAP Earnings per Share(EPS) of -0.25. The EPS decreased by -46.01% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -57.25%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%N/A
Sales Q2Q%N/A
EPS 1Y (TTM)-46.01%
Revenue 1Y (TTM)N/A

IZTC Ownership and Analysts


Ownership
Inst Owners1.21%
Ins Owners27.99%
Short Float %N/A
Short RatioN/A
Analysts
AnalystsN/A
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A